Remdantry (infliximab)

pCPA File Number: 23071
Negotiation Status:
Concluded with an LOI
Indication(s):
Multiple Indications
Sponsor/Manufacturer:
Celltrion Healthcare Canada Ltd.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: